Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Orion Nutraceuticals Inc | 13.0M | -219.8x | --- |
Nass Valley Gateway Ltd | 10.9M | -6.3x | --- |
Pharmacielo Ltd | 14.1M | -0.9x | --- |
Mountain Valley MD Holdings Inc | 9.9M | -1.3x | --- |
Australis Capital Inc | 7.8M | -0.4x | --- |
Aion Therapeutic Inc | 7.1M | -0.9x | --- |
Orion Nutraceuticals Inc. is a Canada-based company. The Company is primarily focused on re-purposing a United States food and drug administration approved drug to target asthma and chronic obstructive pulmonary disease (COPD).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $13.0M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 29.3M |
Orion Nutraceuticals Inc does not pay a dividend. | |
Beta | --- |
EPS | $0.00 |
Book Value | $-0.03 |
P/E Ratio | -219.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.